Sentences with phrase «impact of its programs on»

LiUNA contends that the impact of the program on the construction industry was left out of the recent federal parliamentary review, which released its report and recommendations on September 19.

The educational impact of this program on the congregations — in terms of their understanding of alcoholism and their acceptance of alcoholics — has been a valuable by - product.

This study, conducted by researchers in the Harvard Medical School Department of Health Care Policy, is the first to measure the early impact of the program on the experiences of patients enrolled in ACOs.

One year after the end of the intervention, 36 months after the productive asset transfer, 8 out of 10 indices still showed statistically significant gains, and there was very little or no decline in the impact of the program on the key variables (consumption, household assets, and food security).

Motivational Tools When trying to determine how to implement rewards in your classroom, you need to consider your goals, the kinds of incentives youll use, and the impact of the program on students.

But designers of elearning courses should carefully consider the contents, including the description, subjects, and graphics, and their impact of their programs on their prospective adult learners.

Motivational Tools When trying to determine how to implement rewards in your classroom, you need to consider your goals, the kinds of incentives you'll use, and the impact of the program on students.

The impact of the program on the reading achievement of Cohort 1 students did not differ by a statistically significant amount from the impact of the program on the reading achievement of Cohort 2 students, Carnoy's claim notwithstanding.

The most important aspect of the sessions is that the students can see the direct impact of their programming on the robot, a huge motivational factor.

If you're wanting to use a STEM education program that hasn't been evaluated, Rosicka says it's important to consider how the impact on student learning will be measured and before you allocate any funding or staff time get in touch with the program provider and ask three questions: Is there existing evidence of the impact of this program on students» learning?

The best explanation for the lesser impact of the program on Hispanic students is that they were more likely to enroll in college even in the absence of a voucher.

There was no significant difference between the impact of the program on math and literacy scores when we examined the subjects separately.

Teachers, bureaucrats and principals must sustain their commitment to actively contribute to the critique and reconstruction of teacher preparation, and be central to, course design and accreditation, the delivery of the course and the assessment of impact of programs on student learning.

«[T] here were no statistically significant impacts of the program on reading or math achievement in the first year.»

In December 2014, RAND released a report looking at the impact of the programming on children in the near - term — that is, in the fall after the children took part in the first summer of programming.

Assisting schools in identifying and collecting evidence about the impact of the program on their school community

The report examined the impact of the program on student achievement for students taught directly by Fellows and students taught by Mentees.

Separately, the study also examined the impact of the programs on all students who were offered access, whether or not they actually attended.

The local evaluation gauges the impact of the program on participating students and families, including student attendance, student engagement during the school day and during the afterschool program, parental involvement, and skills acquired by parents.

Through this mixed - methods approach, SRI triangulated data on program implementation, understood contextual factors that influenced implementation, and assessed the impact of the program on teachers and students.

The measurable benefits of animal control programs are unknown and the aim of this study was to determine the impact of these programs on pet population changes.

In the future, we would recommend further studies to further explore the impacts of the program on the welfare of community dogs and the possibility of implementing this program in other regions facing issues with free roaming dogs.

The positive impact of these programs on the number of animals entering municipal shelters is dramatic and very welcome.

RGGI has never quantified the potential impacts of their program on global warming.

703-772-2530, [email protected] Capital Bikeshare Releases Two New Survey ReportsSurveys Provide Detailed Data on Bikeshare Usage and Regional Impact (Washington, D.C.) Today Capital Bikeshare released two new reports that provide detailed information on how members are utilizing the system, the types of trips they make and the overall impact of the program on the members» health.

Stoica believes that even one additional year of the current funding would enable the currently - funded organizations to demonstrate the strong and cost - effective impact of their programs on families and society.

In a world - first, nib foundation's funding support will enable Smiling Mind to conduct the largest evaluation of an app - based mindfulness intervention program - to measure the impact of their program on increasing the protective factors associated with mental health and wellbeing such as social connection, sleep quality, and developing personal coping skills and resilience to deal with the stresses of everyday life.

A beautiful story that represents the impact of our programs on children and families across the state!

Other types of prevention programs may be necessary to reduce more normative types of disruptive behavior among young adolescents.32 In light of the impact of this program on maternal and youth crime and corresponding government expenditures, 8,33 the US Department of Justice is now supporting an effort to make this program available to a larger number of high - crime communities.34

The study will measure the impact of the program on 33 Bronx elementary schools compared to 33 control schools.

In particular, they are examining the impact of the program on bullying and peer victimization.

In particular, they're examining the impact of the program on bullying and peer victimization.

Further research is needed to understand the impact of the program on families, as our results were mixed.

Not exact matches

By focusing on outcomes for Canadians and making evidence - based decisions that are anchored in meaningful data and indicators, the Government is moving to a culture of measurement and impact, and is putting in place the tools to deliver on priorities, align resources to programs and activities that deliver real value for Canadians, and provide meaningful information to Canadians and Parliament.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

The resulting data will help shape the details of the program, and «allow us to focus resources on where the greatest impact will be,» says Bob Annibale, Global Director of Community Development at Citigroup.

«There's a full section that talks about pay equity, and what is the larger impact that the gender pay gap has on our society, our economy, our families,» says Deepti Gudipati, vice president of member leadership programs for the AAUW, who is working with the city to roll out the program.

A team under Airbnb's global head of social impact, Kim Rubey, was already working on a program to house refugee relief workers in Greece, Macedonia and Serbia, but to address the product challenge, Gebbia formed a new team under his Samara studio that was ultimately spun out and called the Human team.

Affiliate - marketing programs can provide a substantial upside to an entrepreneur through their ability to involve a cadre of influencers, someone who has an above - average impact on a specific field and can sawy their social - media following.

The impact of CGI America is charted over time by what they call «progress reports,» which track how talk at the meeting turns into partnerships, programs, funding and jobs on the ground.

The Defense Loan and Technical Assistance (DELTA) Program was implemented to help ease the impact of national defense cuts on defense - dependent small businesses.

The good news, according to Pentagon acquisition chief Frank Kendall, is that a range of measures put in place over the last half - decade have made a positive impact on the Pentagon's buying power while trimming costs across a range of major defense programs.

In a separate TriNet survey, 76 percent of respondents said proposed changes to that program would have a negative impact on their companies.

Pitino offered a statement on Tuesday, saying that «these third - party schemes, initiated by a few bad actors, operated to commit a fraud on the impacted universities and basketball programs, including the University of Louisville.»

In early July, the country's tourism secretary, Enrique de la Madrid, announced the government would implement a trial security program in Los Cabos, Cancun, and Acapulco that month, because those areas «are the destinations that concern us most at the moment because of the impact they have on [Mexico's] image abroad.»

Amazon just made a big change to its affiliate program, which could have an impact on the incomes of members ranging from YouTube stars to traditional media companies.

Of course, when the federal government and states make changes to hunger programs, it has a direct and hard - hitting impact on the groups that act as a safety net.

For all these reasons, and as both a corporate wellness executive and a doctor whose wellness center is deliberately located on a working farm — given its profound healing impact, I find employee gardens to be the most exciting of the new generation of corporate wellness programs.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In developing the National OCS Program, which has also been known as a Five Year Program, the Secretary is required to achieve an appropriate balance among the potential for environmental impacts, for discovery of oil and gas, and for adverse effects on the coastal zone.